Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Herpes simplex Infection

  Free Subscription


Articles published in Antiviral Res

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    July 2025
  1. ELSAYED AMA, Kurose M, Higashiura A, Yamamoto A, et al
    Suppression of herpes simplex virus type 1 replication by Pin1 inhibitors: insights from H-77 and novel compounds.
    Antiviral Res. 2025;241:106244.
    PubMed     Abstract available


    March 2025
  2. BIRKMANN A, Saunders R
    Overview on the management of herpes simplex virus infections: Current therapies and future directions.
    Antiviral Res. 2025;237:106152.
    PubMed     Abstract available


    November 2024
  3. HU Z, Liu W, Liu J, Zhou H, et al
    The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer.
    Antiviral Res. 2024 Nov 11:106035. doi: 10.1016/j.antiviral.2024.106035.
    PubMed     Abstract available


    August 2024
  4. SZEMERE ZK, Murphy EA
    Import of extracellular 2'-3'cGAMP by the folate transporter, SLC19A1, establishes an antiviral response that limits Herpes Simplex Virus-1.
    Antiviral Res. 2024 Aug 16:105989. doi: 10.1016/j.antiviral.2024.105989.
    PubMed     Abstract available


  5. ZHENG S, Verjans GMGM, Evers A, van den Wittenboer E, et al
    CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation.
    Antiviral Res. 2024;228:105950.
    PubMed     Abstract available


    June 2024
  6. PEI J, Tian Y, Dang Y, Ye W, et al
    Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection.
    Antiviral Res. 2024;228:105936.
    PubMed     Abstract available


  7. CHEN SH, Damborsky JC, Wilson BC, Fannin RD, et al
    alpha7 Nicotinic Receptor Activation Mitigates Herpes Simplex Virus Type 1 Infection in Microglia Cells.
    Antiviral Res. 2024 Jun 14:105934. doi: 10.1016/j.antiviral.2024.105934.
    PubMed     Abstract available


    May 2024
  8. EL-MAYET FS, Santos VC, Wijesekera N, Lubbers S, et al
    Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication.
    Antiviral Res. 2024;225:105870.
    PubMed     Abstract available


    November 2023
  9. BERNSTEIN DI, Sawtell NM, Bravo FJ, Dixon DA, et al
    Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV.
    Antiviral Res. 2023;219:105733.
    PubMed     Abstract available


    August 2023
  10. GIORGI J, Simon B, Destras G, Semanas Q, et al
    Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
    Antiviral Res. 2023;216:105672.
    PubMed     Abstract available


    July 2023
  11. FENG Y, Yang Y, Zou S, Qiu S, et al
    Identification of alpha-linolenic acid as a broad-spectrum antiviral against zika, dengue, herpes simplex, influenza virus and SARS-CoV-2 infection.
    Antiviral Res. 2023 Jul 8:105666. doi: 10.1016/j.antiviral.2023.105666.
    PubMed     Abstract available


    May 2023
  12. CIVRA A, Costantino M, Ronchi G, Pontini L, et al
    Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replication.
    Antiviral Res. 2023;215:105634.
    PubMed     Abstract available


  13. PACHOTA M, Grzywa R, Iwanejko J, Synowiec A, et al
    Novel inhibitors of HSV-1 protease effective in vitro and in vivo.
    Antiviral Res. 2023;213:105604.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Herpes simplex Infection is free of charge.